The aim of this study was to describe the epidemiology and clinical impact of carbapenem-nonsusceptible Pseudomonas aeruginosa (CNPA) in intensive care units (ICUs) of the national referral hospital of Indonesia. Adult patients admitted to ICUs were prospectively included. Pseudomonas aeruginosa were from clinical cultures and systematic screening. Environmental niches and healthcare workers (HCWs) were also screened. Susceptibility was determined phenotypically and the presence of carbapenemase genes was determined by PCR. Multiple loci variable-number tandem repeat analysis (MLVA) and multilocus sequence typing (MLST) were used for genotyping. Of the patients included in the study, 17/412 (4.1%) carried CNPA on admission and 34/395 (8.6%) became positive during their ICU stay. The acquisition rate was 18/10 0 0 patient-days at risk. Of 16 environmental isolates, 12 (75.0%) were CNPA. HCWs screened negative. Acquisition of CNPA was associated with longer ICU stay (adjusted hazard ratio = 1.89, 99% confidence interval 1.12-3.13). Mortality was > 40% among patients with CNPA versus < 30% among those without CNPA ( P = 0.019). Moreover, 83/119 (69.7%) CNPA carried either bla VIM ( n = 36), bla IMP ( n = 23) or bla GES-5 ( n = 24). Four sequence types (STs) dominated (ST235, ST823, ST446 and ST357). Five major MLVA clusters were distinguished, two belonging to ST235 and the other three to ST823, ST446 and ST357. CNPA are introduced into these ICUs and some strains expand clonally among patients and the environment, creating endemic CNPA. VIM-, IMP-and GES-5 genes are prevalent. CNPA acquisition was associated with prolonged ICU stay and may affect ICU survival. (J.A. Severin). pseudomonal infections [1] . Non-susceptibility to carbapenem antibiotics in P. aeruginosa is usually due to either a combination of mechanisms, including β-lactamase production, increased efflux pump activity and outer membrane modifications or to production of a carbapenemase as a single potent resistance mechanism; VIM, IMP and GES-5 carbapenemases are most commonly found around the world [2] .
Introduction
The worldwide emergence of carbapenem-non-susceptible Pseudomonas aeruginosa (CNPA) compromises the treatment of ARTICLE IN PRESS JID: ANTAGE [m5G; October 11, 2019; 10:37 ] In 2011, 21.9% of P. aeruginosa strains from the intensive care units (ICUs) of the national referral hospital in Jakarta were carbapenemresistant, and four P. aeruginosa isolates contained the bla IMP gene [3] . The aim of this study was to further delineate the clinical impact and molecular epidemiology of CNPA in ICUs of this hospital.
Materials and methods

Study design
A prospective observational study was performed from April-October 2013 and from April-August 2014 in the 12-bed adult ICU and 8-bed emergency room (ER)-ICU of Dr Cipto Mangunkusumo General Hospital (Jakarta, Indonesia), with an average of 1010 and 415 admissions per year, respectively. Both ICUs are open-plan wards [4] .
Adult patients (age ≥18 years) admitted for > 48 h were eligible. The first screening cultures were taken on the day of ICU admission. Informed consent was obtained from the patients or their relatives. Demographic and clinical characteristics were recorded on admission. Systemic inflammatory response syndrome (SIRS) and quick Sequential Organ Failure Assessment (qSOFA) score on admission were calculated.
The primary outcome measure was acquisition of a CNPA beyond 48 h of ICU admission. Acquisition of CNPA was defined as first detection of CNPA in a screening or clinical culture. Secondary outcome measures were ICU length of stay (LoS) and in-ICU mortality.
Screening cultures were obtained from the throat and rectum or stools on the day of admission, at the time of discharge from the ICU, and weekly if the patient's stay exceeded 7 days. Sterile cotton-tipped swabs were used for sampling, which were processed within 24 h. Additional samples were collected on clinical indication.
The environment was sampled twice in both ICUs (Supplementary Table S1 ). Screening of healthcare workers (HCWs) was performed once by throat and rectal swabs. HCWs were defined as all personnel (doctors, nurses, cleaning staff, administration staff, porters, nutritionist) working in the ICUs.
Microbiological methods
Isolation and identification
Swabs for screening were placed in 5 mL of trypticase soy broth (TSB) with 2 mg/L cefotaxime and 50 mg/L vancomycin, were incubated overnight and were subsequently subcultured on Mac-Conkey agar, followed by identification of suspected colonies using VITEK R 2 (bioMérieux, Marcy-l'Étoile, France). Blood cultures were collected in BACTEC R (BD, Franklin Lakes, NJ, USA) bottles. Other clinical specimens were inoculated onto blood and Mac-Conkey agar plates and were processed as above. P. aeruginosa strains were stored at -80 °C in TSB with 10% v/v glycerol. Their identity was confirmed at Erasmus MC (Rotterdam, the Netherlands) by mass spectrometry (MALDI Biotyper R ; Bruker, Coventry, UK).
Antimicrobial susceptibility testing
Susceptibility of screening isolates to carbapenems was determined by the Kirby-Bauer disk diffusion method using Mueller-Hinton plates (BD). Susceptibility of the clinical isolates was determined by VITEK R 2. Carbapenem zone sizes and minimum inhibitory concentrations (MICs) were interpreted according to European Committee on Antimicrobial Susceptibility Testing (EU-CAST) 2013 breakpoints (meropenem, < 24 mm and MIC > 2 mg/L; imipenem, < 20 mm and MIC > 4 mg/L). For detection of metalloβ-lactamases (MBLs), the imipenem/doripenem combination disk test with ethylene diamine tetra-acetic acid (EDTA) was performed [5] .
DNA extraction and carbapenemase gene detection
DNA was extracted using InstaGene TM Matrix (Bio-Rad Laboratories, Hercules, CA, USA). PCR for Ambler class B MBLs ( bla NDM , bla VIM and bla IMP ) was carried out using a T30 0 0 Thermocycler (Biometra-Whatman, Germany) [6] .
Clonal relatedness
Multiple loci variable-number tandem repeat analysis (MLVA) and in silico multilocus sequence typing (MLST) were used for typing ( Supplementary Table S2 ) [7] . Briefly, 2 μL of 100 × diluted PCR product was analysed on an ABI3130xl Genetic Analyzer (Thermo Fisher Scientific, USA). Electropherograms were analysed using the MLVA plugin in BioNumerics R v.7.6 (Applied Maths, Sint-Martens-Latem, Belgium). Typing data were analysed categorically.
MLST sequence types (STs) as well as carbapenemase gene subtypes were inferred from whole-genome sequencing data using the MLST plugin and sequence extraction tool from BioNumerics R v.7.6. The classical 7-digit in silico MLST profiles were obtained through BLAST using the PubMLST database hosted at https:// pubmlst.org . Sequencing was performed using a HiSeq 2500 instrument (Illumina Inc., San Diego, CA, USA).
Statistical analysis
IBM SPSS Statistics v.24.0 (IBM Corp., Armonk, NY) was used for statistical analysis. Patients admitted to the adult ICU were compared with those admitted to the ER-ICU using χ 2 test or Fisher's exact test and Mann-Whitney U -test as appropriate. One-way analysis of variance (ANOVA) was used to compare patient characteristics according to their P. aeruginosa status. Univariate and multivariate analyses were performed to establish risk factors associated with mortality using a multivariate logistic regression model with backward selection and inclusion of variables with a P -value of < 0.1 in the univariate analysis. Cox proportional regression was used to analyse risk factors for LoS. The Kaplan-Meier method was performed to construct survival curves. A P -value of < 0.01 was considered statistically significant [8] .
Results
Patient characteristics and outcomes
A total of 1211 patients were hospitalised in the ICUs (adult ICU, n = 863; ER-ICU, n = 348), of which 412 were included in this study (adult ICU, n = 188; ER-ICU, n = 224). Most of the non-eligible patients were excluded due to short LoS. There were no significant differences between patients in both ICUs, except that in the adult ICU most patients had been referred from another ward and more patients had malignancies ( Supplementary Table S3 ). Therefore, data from the ICUs were analysed both separately and pooled.
Overall, 145/412 (35.2%) patients had at least one positive culture with P. aeruginosa , whereas the remaining 267 patients were free from P. aeruginosa on admission and during their ICU stay ( Table 1 ) days; adjusted hazard ratio (aHR) = 1.89, 99% confidence interval (CI) 1.12-3.13; P = 0.002) ( Supplementary Table S4 ; Fig. 1 B) compared with the other groups of patients, of whom ≥80% were discharged from the ICU within 7-12 days. These latter groups included patients who were always free from P. aeruginosa , patients who already carried P. aeruginosa (either CSPA or CNPA) at the time of ICU admission, and patients who became positive for CSPA during their ICU stay.
A longer LoS was independently associated with mechanical ventilation ≥5 days (median [IQR] LoS, 10 [7-15] days; aHR = 3.09, 99% CI 1.98-4.83; P < 0.001) ( Supplementary Table S4 ) and use of a urinary catheter ≥5 days (median [IQR] LoS, 8 [5] [6] [7] [8] [9] [10] [11] [12] days; aHR = 3.03, 99% CI 1.73-5.30; P < 0.001) ( Supplementary Table S4 ). Acquisition of P. aeruginosa was not associated with in-ICU mortality: 27.7% (74/267) of patients who remained free of P. aeruginosa died versus 14.7% (5/34) and 41.2% (14/34) of patients who acquired a CSPA or CNPA, respectively [ Supplementary Table S5 ; adjusted odds ratio (aOR) = 0.41, 99% CI 0.10-1.71; P = 0.109; and aOR = 1.08, 99% CI 0.34-3.46; P = 0.867]. The group of patients who acquired CSPA had the lowest mortality rate, and the probability of ICU survival was higher for patients who acquired a CSPA compared with patients who acquired CNPA (aHR = 4.06, 99% CI 0.87-18.88; P = 0.019) ( Fig. 1 C) . Likewise, the ICU mortality among all patients with CNPA was 22/51 (43.1%) versus 97/361 (26.9%) among patients without CNPA ( P = 0.016). The admission SIRS and qSOFA scores of patients with or without P. aeruginosa acquisition did not differ, indicating that significant differences in the risk of dying were not present at the time of ICU admission but emerged later during their ICU stay ( Supplementary Table S5 ). In multivariate comparison, patients who acquired a CNPA during their ICU stay were more likely to have had prior exposure to antibiotics, especially carbapenems (aOR = 2.67, 99% CI 0.94-7.62; P = 0.015).
Phenotypic and molecular characterisation of carbapenem-non-susceptible Pseudomonas aeruginosa
Overall, 107/281 (38.1%) isolates from 51/145 patients were found to be non-susceptible to carbapenems. Moreover, 12/16 (75.0%) P. aeruginosa isolates from the environment were CNPA (Supplementary Table S6 ). None of 25 isolates from HCWs were CNPA. Thus, 119 CNPA were subjected to further analyses. Phenotypic testing showed that 68/119 (57.1%) isolates produced a MBL. PCR demonstrated the presence of bla VIM in 36 and bla IMP in 23, including isolates from patients and the environment. None of the 119 isolates were positive for bla NDM . The presence of non-MBL bla GES-5 was detected in 24 isolates.
Clonal relatedness
MLST revealed four major clusters (ST235, ST823, ST446 and ST357) as well as several new sequence types. By MLVA, five major clusters were distinguished, two belonging to ST235 and the others corresponding to ST823, ST446 and ST357 ( Fig. 2 A) . These four major genetic clusters included 97/107 (90.7%) CNPA from patients (ICU-imported and ICU-acquired) as well as 11/12 (91.7%) environmental isolates ( Fig. 2 B) . Most isolates belonged to ST235 (10 imported, 32 acquired patient isolates and 4 environmental isolates), of which 22 isolates harboured bla IMP , 24 isolates harboured bla GES-5 but no isolates contained bla VIM . All ST823 isolates harboured bla VIM ( Supplementary Tables S6 and S7 ).
Discussion
Reports describing the emergence of P. aeruginosa isolates harbouring carbapenemase genes come from different parts of the world, including Southeast Asia [9] . In the current study, it was found that 12.4% of patients who stayed in our ICUs for > 2 days carried CNPA and 4.1% of patients were already colonised at ICU admission. Patients may become colonised elsewhere in the same hospital or in another hospital from which they are referred, or they may come with such a strain directly from the community, possibly having acquired the strain during previous healthcare contact or indirectly from exposure to relatives carrying such strains or unknown environmental niches.
Hence, screening cultures are indispensable for early detection and infection control. This will also guide rational antibiotic use since it has been shown that colonisation with CNPA is a risk factor for infection [10] . The current data show that patient acquisition of CNPA during ICU care is associated with prolonged ICU stay. Acquisition of CSPA or CNPA was statistically not associated with mortality compared with patients free of P. aeruginosa . However, the observed mortality rate was much higher among patients with CNPA versus those without. A study in Taiwan in 2016 also did not find carbapenem resistance to be associated with mortality [11] , whereas another study revealed a relationship between CNPA carriage and mortality [12] .
Among the 107 CNPA, bla VIM , bla IMP and bla GES-5 were the most prevalent carbapenemase genes. These genes are widely distributed in the world. The first MBL found in P. aeruginosa was IMP-1, identified in Japan in 1988. VIM was first identified in Italy in 1997, but reached Southeast Asia [ 2 , 9 ] . GES-5-producing P. aeruginosa was first detected in China in 2004 and has been isolated globally since [13 , 14] .
In a recent review it was shown that use of carbapenems and medical devices are the leading risk factors for carriage of CNPA [15] . The authors also identified environmental sources of CNPA, with sinks being the most frequently reported reservoirs [16] . More recent reports of outbreaks of CNPA also demonstrate an association with environmental contamination [17] [18] [19] . This phenomenon was also observed in our setting. The four environmental bla IMPpositive ST235 CNPA were all cultured from wet sources in the common cleaning room. In this room, located adjacent to the adult ICU, all reusable items are manually cleaned and stored. These types of 'wet' rooms may serve as a persistent source and route of transmission for resistant bacteria and should be targeted by infection control.
MLST revealed four major clusters (ST235, ST823, ST446 and ST357) and several new clones. ST235 is the most prevalent of the so-called 'international' clones that are associated with poor clinical outcomes [20] . The Indonesian offspring of this clone, identified in this study, always harboured bla IMP or bla GES-5 , but not bla VIM . All ST823 isolates consistently harboured only bla VIM , and only bla IMP was found in ST357, but no genes in ST446. Three dominant clusters included isolates from the ICU environment (ST235, ST823 and ST446). This epidemiological information should be used when designing interventions to reduce the acquisition of CNPA in ICUs in Indonesia and similar settings elsewhere.
This study has limitations. First, it was a single-centre study, therefore the data are not representative for the whole country. Second, we were unable to evaluate the effect of several other possible confounders of CNPA acquisition, including long-term kidney dialysis, use of inotropes, surgery and previous hospital admission.
Conclusion
This large prospective study describes the epidemiology and clinical impact of CNPA in ICUs in Indonesia. Acquisition of CNPA in ICUs was independently associated with prolonged LoS and possibly survival. ST235 was the dominant clone, as were IMP, VIM and GES carbapenemases. Controlling CNPA requires admission 
